Femynor and Omalizumab Subcutaneous
Determining the interaction of Femynor and Omalizumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ethinyl estradiol / norgestimate
Brand name: Estarylla, Femynor, Mono-Linyah, Mononessa, Ortho Tri-Cyclen, Previfem, Sprintec, Tri-Lo-Marzia, TriNessa, Ortho Tri-Cyclen, Ortho-Cyclen, Sprintec 28, Tri-Lo-Marzia>
Synonyms: n.a.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Femynor-Ombitasvir, Paritaprevir, and Ritonavir
- Femynor-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Femynor-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Femynor-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Femynor-Omeclamox-Pak
- Femynor-Omega-3 Fatty Acid Capsules
- Omalizumab Subcutaneous-Fenesin DM IR
- Omalizumab Subcutaneous-Fenicol
- Omalizumab Subcutaneous-Fenofibrate
- Omalizumab Subcutaneous-Fenofibrate and Derivatives
- Omalizumab Subcutaneous-Fenofibrate and Derivatives Capsules
- Omalizumab Subcutaneous-Fenofibrate and Derivatives Tablets